Mast Cell-Dependent Contraction of Human Airway Smooth Muscle Cell-Containing Collagen Gels: Influence of Cytokines, Matrix Metalloproteases, and Serine Proteases

In asthma, mast cells infiltrate the airway smooth muscle cell layer and secrete proinflammatory and profibrotic agents that contribute to airway remodeling. To study the effects of mast cell activation on smooth muscle cell-dependent matrix contraction, we developed coculture systems of human airway smooth muscle cells (HASM) with primary human mast cells derived from circulating progenitors or with the HMC-1 human mast cell line. Activation of primary human mast cells by IgE receptor cross-linking or activation of HMC-1 cells with C5a stimulated contraction of HASM-embedded collagen gels. Contractile activity could be transferred with conditioned medium from activated mast cells, implicating involvement of soluble factors. Cytokines and proteases are among the agents released by activated mast cells that may promote a contractile response. Both IL-13 and IL-6 enhanced contraction in this model and the activity of IL-13 was ablated under conditions leading to expression of the inhibitory receptor IL-13Rα2 on HASM. In addition to cytokines, matrix metalloproteinases (MMPs), and serine proteases induced matrix contraction. Inhibitor studies suggested that, although IL-13 could contribute to contraction driven by mast cell activation, MMPs were critical mediators of the response. Both MMP-1 and MMP-2 were strongly expressed in this system. Serine proteases also contributed to contraction induced by mast cell-activating agents and IL-13, most likely by mediating the proteolytic activation of MMPs. Hypercontractility is a hallmark of smooth muscle cells in the asthmatic lung. Our findings define novel mechanisms whereby mast cells may modulate HASM-driven contractile responses.

[1]  A. Knox,et al.  Use of a three-dimensional cell culture model to study airway smooth muscle-mast cell interactions in airway remodeling. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[2]  A. Margulis,et al.  MMP dependence of fibroblast contraction and collagen production induced by human mast cell activation in a three-dimensional collagen lattice. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[3]  H. Sakai,et al.  Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein. , 2009, American journal of respiratory cell and molecular biology.

[4]  C. Brightling,et al.  Mast Cells Promote Airway Smooth Muscle Cell Differentiation via Autocrine Up-Regulation of TGF-β11 , 2008, The Journal of Immunology.

[5]  C. Brightling,et al.  Human Airway Smooth Muscle Promotes Human Lung Mast Cell Survival, Proliferation, and Constitutive Activation: Cooperative Roles for CADM1, Stem Cell Factor, and IL-61 , 2008, The Journal of Immunology.

[6]  I. Pavord,et al.  Airway hyperresponsiveness is dissociated from airway wall structural remodeling. , 2008, The Journal of allergy and clinical immunology.

[7]  Douglas K. Miller,et al.  IL-13 as a therapeutic target for respiratory disease. , 2008, Biochemical pharmacology.

[8]  A. James,et al.  Extracellular matrix components and regulators in the airway smooth muscle in asthma , 2008, European Respiratory Journal.

[9]  A. Knox,et al.  Tryptase activates TGFbeta in human airway smooth muscle cells via direct proteolysis. , 2008, Biochemical and biophysical research communications.

[10]  O. Kaminuma,et al.  A Contraction Assay System Using Established Human Bronchial Smooth Muscle Cells , 2008, International Archives of Allergy and Immunology.

[11]  Yushi Ito,et al.  Dual Modulation of Airway Smooth Muscle Contraction by Th2 Cytokines via Matrix Metalloproteinase-1 Production1 , 2008, The Journal of Immunology.

[12]  I. Pavord,et al.  Increased sputum and bronchial biopsy IL-13 expression in severe asthma. , 2008, The Journal of allergy and clinical immunology.

[13]  W. Hubbard,et al.  Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. , 2008, The Journal of allergy and clinical immunology.

[14]  J. Stankova,et al.  Interleukin-4 and Interleukin-13 Enhance Human Bronchial Smooth Muscle Cell Proliferation , 2008, International Archives of Allergy and Immunology.

[15]  K. Fukuda,et al.  Roles of Galectin-9 in the Development of Experimental Allergic Conjunctivitis in Mice , 2007, International Archives of Allergy and Immunology.

[16]  H. Matsumoto,et al.  Comparison of gel contraction mediated by airway smooth muscle cells from patients with and without asthma , 2007, Thorax.

[17]  F. Bucchieri,et al.  Effect of IL-13 receptor alpha2 levels on the biological activity of IL-13 variant R110Q. , 2007, The Journal of allergy and clinical immunology.

[18]  B. Levy,et al.  Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines. , 2007, American journal of respiratory cell and molecular biology.

[19]  R. Jörres,et al.  IL-13Rα2 Reverses the Effects of IL-13 and IL-4 on Bronchial Reactivity and Acetylcholine-Induced Ca2+ Signaling , 2006, International Archives of Allergy and Immunology.

[20]  W. Calhoun,et al.  The role of leukotrienes in airway inflammation. , 2006, The Journal of allergy and clinical immunology.

[21]  D. Wakefield,et al.  Human Mast Cell-Derived Gelatinase B (Matrix Metalloproteinase-9) Is Regulated by Inflammatory Cytokines: Role in Cell Migration1 , 2006, The Journal of Immunology.

[22]  Y. Tabata,et al.  Level of Expression of IL-13Rα2 Impacts Receptor Distribution and IL-13 Signaling1 , 2006, The Journal of Immunology.

[23]  S. Holgate,et al.  The role of the mast cell in the pathophysiology of asthma. , 2006, The Journal of allergy and clinical immunology.

[24]  G. Hou,et al.  Doxycycline alters vascular smooth muscle cell adhesion, migration, and reorganization of fibrillar collagen matrices. , 2006, The American journal of pathology.

[25]  A. Yamasaki,et al.  Airway smooth muscle phenotype and function: interactions with current asthma therapies. , 2006, Current drug targets.

[26]  C. Brightling,et al.  Mast cell migration to Th2 stimulated airway smooth muscle from asthmatics , 2006, Thorax.

[27]  K. Fukuda,et al.  Activation of Corneal Fibroblast–Derived Matrix Metalloproteinase-2 by Tryptase , 2006, Current eye research.

[28]  R. Puri,et al.  IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis , 2006, Nature Medicine.

[29]  Hiroyuki Tanaka,et al.  Production of matrix metalloproteinases in human cultured mast cells: involvement of protein kinase C-mitogen activated protein kinase kinase-extracellular signal-regulated kinase pathway. , 2006, Allergology international : official journal of the Japanese Society of Allergology.

[30]  I. Adcock,et al.  Induction and regulation of matrix metalloproteinase-12in human airway smooth muscle cells , 2005, Respiratory research.

[31]  T. Kawakami,et al.  Mast Cell Survival and Activation by IgE in the Absence of Antigen: A Consideration of the Biologic Mechanisms and Relevance1 , 2005, The Journal of Immunology.

[32]  Q. Hamid,et al.  Human Airway Smooth Muscle Cells Express the High Affinity Receptor for IgE (FcεRI): A Critical Role of FcεRI in Human Airway Smooth Muscle Cell Function , 2005, The Journal of Immunology.

[33]  C. Brightling,et al.  The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. , 2005, American journal of respiratory and critical care medicine.

[34]  G. Davis,et al.  MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices , 2005, Journal of Cell Science.

[35]  A. Clowes,et al.  MMP-9 regulates both positively and negatively collagen gel contraction: a nonproteolytic function of MMP-9. , 2005, Cardiovascular research.

[36]  P. Eyre,et al.  The Schultz-Dale reaction: A review , 1978, Agents and Actions.

[37]  S. Watson,et al.  Matrix metalloproteinase expression and activity in human airway smooth muscle cells , 2004, British journal of pharmacology.

[38]  D. Robinson The role of the mast cell in asthma: induction of airway hyperresponsiveness by interaction with smooth muscle? , 2004, The Journal of allergy and clinical immunology.

[39]  H. Matsuda,et al.  IgE crosslinkage of Fcepsilon receptor I induces both production and activation of matrix metalloproteinase-9 in mast cells. , 2004, Cellular immunology.

[40]  N. Otori,et al.  TNF-α and IL-4 regulate expression of IL-13 receptor α2 on human fibroblasts , 2003 .

[41]  Qing Yang,et al.  The negative-feedback regulation of the IL-13 signal by the IL-13 receptor alpha2 chain in bronchial epithelial cells. , 2003, Cytokine.

[42]  I. Pavord,et al.  Interleukin‐4 and ‐13 expression is co‐localized to mast cells within the airway smooth muscle in asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[43]  R. Marthan,et al.  Tryptase‐stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell Chemotaxis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  R. Panettieri,et al.  IL-13 and IL-4 promote TARC release in human airway smooth muscle cells: role of IL-4 receptor genotype. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[45]  Stephen T. Holgate,et al.  Kinetic Analysis of the Interleukin-13 Receptor Complex* , 2002, The Journal of Biological Chemistry.

[46]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[47]  A. James,et al.  Distribution and degranulation of airway mast cells in normal and asthmatic subjects , 2002, European Respiratory Journal.

[48]  A. Ammit,et al.  Human mast cell and airway smooth muscle cell interactions: implications for asthma. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[49]  R. Marthan,et al.  Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. , 2001, Journal of applied physiology.

[50]  H. Hoogsteden,et al.  Pro-inflammatory cytokines induce c-fos expression followed by IL-6 release in human airway smooth muscle cells. , 2001, Mediators of inflammation.

[51]  P. Hart Regulation of the inflammatory response in asthma by mast cell products , 2001, Immunology and cell biology.

[52]  R. Geary,et al.  Hyaluronan Enhances Contraction of Collagen by Smooth Muscle Cells and Adventitial Fibroblasts: Role of CD44 and Implications for Constrictive Remodeling , 2001, Circulation research.

[53]  J. Wallace,et al.  Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells. , 2000, The Journal of allergy and clinical immunology.

[54]  U. Ikeda,et al.  Interaction between monocytes and vascular smooth muscle cells enhances matrix metalloproteinase-1 production. , 2000, Journal of cardiovascular pharmacology.

[55]  A. Knox,et al.  Autocrine production of matrix metalloproteinase-2 is required for human airway smooth muscle proliferation. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[56]  Cecilia Kim,et al.  Altered expression and action of the low-affinity IgE receptor FcϵRII (CD23) in asthmatic airway smooth muscle , 1999 .

[57]  M. Kurosawa,et al.  Human mast cells produce matrix metalloproteinase 9 , 1999, European journal of immunology.

[58]  B. Schnyder,et al.  The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[59]  M. Grunstein,et al.  Autologously up-regulated Fc receptor expression and action in airway smooth muscle mediates its altered responsiveness in the atopic asthmatic sensitized state. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[60]  A. Ammit,et al.  Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus. , 1997, The European respiratory journal.

[61]  G. Nilsson,et al.  C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. , 1996, Journal of immunology.

[62]  M. Oppermann,et al.  The Human Mast Cell Line HMC‐1 Expresses C5a Receptors and Responds to C5a but not to C5a(desArg) , 1996, Scandinavian journal of immunology.

[63]  M. Manns,et al.  Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls. , 1996, Gut.

[64]  P. Libby,et al.  Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[65]  S. Dahlén,et al.  Interactions between leukotrienes and histamine in the anaphylactic contraction of guinea pig lung parenchyma. , 1994, The Journal of pharmacology and experimental therapeutics.

[66]  P. Libby,et al.  Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. , 1994, Circulation research.

[67]  S. Dahlén,et al.  Leukotrienes and histamine mediate IgE-dependent contractions of human bronchi: pharmacological evidence obtained with tissues from asthmatic and non-asthmatic subjects. , 1993, Pulmonary pharmacology.

[68]  P. de Lanerolle Airway smooth muscle and asthma. , 1992, American journal of respiratory cell and molecular biology.

[69]  P. Roche,et al.  Purification of Tryptase From a Human Mast Cell Line , 1990, Journal of leukocyte biology.